ScholarIQanswers from OpenAlex

MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer

PaperCitations, authors & open-access status

MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer have?

ScholarIQcitation count

MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer has 75 citations in the OpenAlex counts ScholarIQ stores.

When was MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer published?

ScholarIQyear

MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer has 2014 year in the ScholarIQ index.

What is the open-access status of MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer?

ScholarIQoa status

MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer has gold oa status in the ScholarIQ index.

What is the DOI of MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer?

ScholarIQdoi

The DOI for MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer is on the source record.

What is the PMID of MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer?

ScholarIQpmid

The PMID for MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer is on the source record.

What is the OpenAlex record for MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer?

ScholarIQopenalex

The OpenAlex for MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial